The total of American health spending is the sum of spending for each individual. And each individual has a spending arc during the course of their live. The average of all these spending arcs can itself be informative. A report from the Society of Actuaries using Health Care Cost Institute and Medicare fee-for-service data examines spending at various ages. (HCCI Report) As might be expected, spending generally rises during each year of life, particularly once adulthood is reached. Male costs are lower than female ones up until about age 55, largely due to childbirth and related expenses. For the Medicare population, costs also rise each year after age 65, although they flatten for males after age 95 and actually decline for females after age 90. Changing demographics–age and gender–account for only about 7 to 10% of the real per capita growth in health spending. The health reform law’s limits on age-adjusting of premiums means that younger people will pay more and older ones less, which means that young people will increasingly subsidize the health spending of older ones. And of course, eliminating a gender rating difference forces males to subsidize female costs. Raising the age for Medicare eligibility would lower overall spending but increase per capita costs. For a person who turns 65, their current estimated out-of-pocket health care costs for their expected remaining life of 20 years would be $146,000. If they lived 25 more years that rises to $220,600. Medicare can expect to pay about $450,000 for a beneficiary turning 65 with 20 years of remaining life expectancy. People with chronic diseases or cancer diagnoses have higher expenses at any age than people without, as might be expected. Now that this basic data set has been created, the effect of various interventions would be interesting to test–looking at cohorts in wellness or disease management programs, looking a people treated in different settings, looking at regional variation.
Health Care Costs Throughout Life
By Kevin RocheJune 3, 2013Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…